L26/P-661 Chromosome-specific pregnancy outcomes after mosaic embryo transfer: disentangling abnormality severity from chromosome identity
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.991 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von S.N. Hwang und 14 weiteren Autor:innen.
Abstract (Originalsprache)
Study question Are chromosome-specific associations with pregnancy outcomes after mosaic embryo transfer independent of mosaicism characteristics and coexisting severe chromosomal abnormalities? Summary answer After excluding coexisting severe chromosomal abnormalities, most chromosome-specific associations were attenuated, suggesting pregnancy outcomes are driven by mosaicism type and level rather than chromosome identity. What is known already Most studies evaluating mosaic embryo transfer have relied on embryo-level classifications based on mosaicism level or abnormality type, with limited attention to chromosome-specific effects on pregnancy outcomes. In addition, it remains unclear whether apparent chromosome-specific associations reflect independent effects of chromosome identity or are confounded by mosaicism characteristics and coexisting more severe chromosomal abnormalities. To address this, we conducted a chromosome-wide analysis comparing pregnancy outcomes in an unrestricted dataset and in a restricted dataset, the latter excluding embryos carrying coexisting chromosomal abnormalities of greater severity than the chromosome of interest. Study design, size, duration This retrospective cohort study analyzed 2,898 single embryo transfers performed following PGT-A at a single fertility center between August 2020 and June 2025, including 2,569 euploid and 329 mosaic embryo transfers. Chromosome-level analyses were first conducted in an unrestricted mosaic cohort. Subsequently, restricted analyses were performed by excluding embryos carrying coexisting chromosomal abnormalities of greater severity than the chromosome of interest. Participants/materials, setting, methods For unrestricted analyses, mosaicism was classified by abnormality type (segmental or whole-chromosome) and level (low or high) of the chromosome of interest, allowing multiple affected chromosomes per embryo. To reduce confounding from coexisting abnormalities, restricted analyses excluded embryos carrying abnormalities of greater severity than the chromosome under evaluation. Associations with clinical and ongoing pregnancy were assessed using Firth penalized logistic regression adjusted for key clinical covariates, with euploid embryos as the reference group. Main results and the role of chance In unrestricted chromosome-level analyses of mosaicism, several chromosomes showed reduced odds of clinical pregnancy compared with euploid embryos. These included whole-chromosome low-level mosaicism involving chromosomes 5 (aOR 0.21, 95% CI 0.04–0.77; p = 0.018) and 18 (aOR 0.19, 95% CI 0.02–0.91; p = 0.037), whole-chromosome high-level chromosomes 19 (aOR 0.06, 95% CI < 0.01–0.49; p = 0.005) and 22 (aOR 0.09, 95% CI < 0.01–0.84; p = 0.032), and segmental low-level chromosomes 20 (aOR 0.15, 95% CI 0.02–0.70; p = 0.014). For ongoing pregnancy, a significant association was observed only for chromosome 19 with whole-chromosome high-level mosaicism (aOR 0.08, 95% CI < 0.01–0.66; p = 0.015). After restricting analyses by excluding embryos with coexisting chromosomal abnormalities of greater severity, significant associations with clinical pregnancy persisted only for chromosome 19 and 22 with whole-chromosome high-level mosaicism (aOR 0.06, 95% CI < 0.01–0.49; p = 0.005 and aOR 0.09, 95% CI < 0.01–0.84; p = 0.032, respectively), while associations for chromosomes 5, 18, and 20 were attenuated and no longer statistically significant. Under restricted criteria, chromosome 19 with whole-chromosome high-level mosaicism remained associated with reduced odds of ongoing pregnancy (aOR 0.08, 95% CI < 0.01–0.66; p = 0.015). Limitations, reasons for caution The retrospective design and clinician-driven embryo selection may introduce residual confounding. Restricted analyses included few transfers per chromosome, particularly within whole-chromosome high-level mosaicism; therefore, residual associations for chromosomes 19 and 22 cannot be disentangled from type×level effects and should be interpreted as exploratory rather than definitive. Wider implications of the findings Most apparent chromosome-specific associations were attenuated after excluding embryos with more severe coexisting abnormalities, supporting mosaicism type and level—rather than chromosome identity—as the primary determinants of pregnancy outcomes after mosaic embryo transfer. Trial registration number No
Zitieren
APA
Hwang, S., Park, E., Kang, M., Kim, H., Park, S., Chang, U., Jeong, J., Oh, S., Choi, J., Lee, K., Han, S., Kim, E., Kim, Y., Kim, H., & Yu, E. (2026). L26/P-661 Chromosome-specific pregnancy outcomes after mosaic embryo transfer: disentangling abnormality severity from chromosome identity. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.991
Vancouver
Hwang S, Park E, Kang M, Kim H, Park S, Chang U, et al. L26/P-661 Chromosome-specific pregnancy outcomes after mosaic embryo transfer: disentangling abnormality severity from chromosome identity. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.991
BibTeX
@article{Hwang2026,
author = {Hwang, S.N. and Park, E.A. and Kang, M. and Kim, H.S. and Park, S. and Chang, U. and Jeong, J.C. and Oh, S.H. and Choi, J.Y. and Lee, K.A. and Han, S.J. and Kim, E.J. and Kim, Y.S. and Kim, H.O. and Yu, E.J.},
title = {L26/P-661 Chromosome-specific pregnancy outcomes after mosaic embryo transfer: disentangling abnormality severity from chromosome identity},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.991}
}
EUVIMED